Patients with hepatitis C virus (HCV) are more likely than HCV-negative patients to display high-risk behavior, and this difference is most pronounced in the post-baby boomer generation, a new study found. The retrospective study quantified the relationship between illicit/prescription drug misuse and HCV infection in 3 population generations: baby boomers (born 1945-1965), pre-baby boomers, and post-baby boomers. Prescription drug consistency and HCV patient test results were included, and HCV positivity, drug use consistency/inconsistency with prescribed drug information, type of inconsistent use, and inconsistent use of individual drug classes were assessed. Researchers found:
- 39,231 prescription drug monitoring and HCV sets of test results from 18,410 patients were evaluated.
- 25.1% of patients tested positive for HCV and 57.3% demonstrated drug test results that were inconsistent with the prescribed medication.
- The types of drug test inconsistency differed substantially between HCV-positive and HCV-negative patients.
- Specimens from HCV-positive baby boomer and post-baby boomers demonstrated non-prescribed use of opioids and other drug classes more often than from HCV-negative patients.
McClure FL, Niles JK, Kaufman HW, Gudin J. Drug misuse and hepatitis C virus infection profiles for three generations of patients being monitored for prescription drug adherence. [Published online ahead of print October 16, 2018]. J Addict Med. doi:10.1097/ADM.0000000000000460.
This Week's Must Reads
Do Vitamin D Supplements Prevent Cancer, CVD?, N Engl J Med; 2019 Jan 3; Manson, Cook, et al
Nonadherence to Cancer Screenings & Related Mortality, JAMA Intern Med; ePub 2018 Dec 28; Pierre-Victor, et al
Alcohol Consumption After Development of HF, JAMA Netw Open; ePub 2018 Dec 28; Sadhu, et al
Opioid-Involved Overdose Deaths in the US, MMWR; 2019 Jan 4; Scholl, Seth, et al
Assessing the Diet Quality of US Children, Am J Clin Nutrit; ePub 2018 Dec 29; Thomson, et al
Must Reads in Hepatitis
Glecaprevir/Pibrentasvir Efficacy & Safety Assessed, J Hepatol; ePub 2018 Nov 23; D’Ambrosio, et al
HCV Infection Among Children & Young Persons, J Hepatol; ePub 2018 Nov 26; Modin, et al
HCV Patients with Limited Access to Antiviral Therapy, Dig Liver Dis; ePub 2018 Nov 29; Lens, et al
Progression in the Elimination of HCV Infection, PLoS One; ePub 2018 Dec 4; Juanbeltz, et al
Increased HCV Screening in Veteran Populations, Jt Comm J Qual Patient Saf; ePub 2018 Sep 25; Wray, et al